1
|
Alonso‐Luna O, Mercado‐Celis GE, Melendez‐Zajgla J, Barquera R, Zapata‐Tarres M, Juárez‐Villegas LE, Mendoza‐Caamal EC, Rey‐Helo E, Borges‐Yañez SA. Germline mutations in pediatric cancer cohort with mixed-ancestry Mexicans. Mol Genet Genomic Med 2024; 12:e2332. [PMID: 38093606 PMCID: PMC10767611 DOI: 10.1002/mgg3.2332] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Revised: 08/11/2023] [Accepted: 11/28/2023] [Indexed: 01/07/2024] Open
Abstract
BACKGROUND Childhood cancer is one of the primary causes of disease-related death in 5- to 14-year-old children and currently no prevention strategies exist to reduce the incidence of this disease. Childhood cancer has a larger hereditary component compared with cancer in adults. Few genetic studies have been conducted on children with cancer. Additionally, Latin American populations are underrepresented in genomic studies compared with other populations. Therefore, the aim of this study is to analyze germline mutations in a group of mixed-ancestry Mexican pediatric patients with solid and hematological cancers. METHODS We analyzed genetic variants from 40 Mexican childhood cancer patients and their relatives. DNA from saliva or blood samples was used for whole-exome sequencing. All variants were identified following GATK best practices. RESULTS We found that six patients (15%) were carriers of germline mutations in CDKN2A, CHEK2, DICER1, FANCA, MSH6, MUTYH, NF1, and SBDS cancer predisposition genes, and additional new variants predicted to be deleterious by in silico algorithms. A population genetics analysis detected five components consistent with the demographic models assumed for modern mixed-ancestry Mexicans. CONCLUSIONS This report identifies potential genetic risk factors and provides a better understanding of the underlying mechanisms of childhood cancer in this population.
Collapse
Grants
- 365882 Consejo Nacional de Ciencia y Tecnología, CONACyT, Mexico
- 253316 Consejo Nacional de Ciencia y Tecnología, CONACyT, Mexico
- Fundacion Carlos Slim as part of the inaugural phase of Slim Initiative in Genomic Medicine for the Americas, SIGMA
- Broad Institute of MIT and Harvard
- Instituto Nacional de Medicina Genomica (INMEGEN)
- Division de Estudios de Posgrado e Investigacion de la Facultad de Odontologia
- Programa de Maestria y Doctorado en Ciencias Medicas, Odontologicas y de la Salud, UNAM
- "Aqui nadie se rinde, ANSER (I.A.P)
- Max Planck Institute for Evolutionary Anthropology (MPI-EVA)
- Consejo Nacional de Ciencia y Tecnología, CONACyT, Mexico
- Max Planck Institute for Evolutionary Anthropology (MPI‐EVA)
Collapse
Affiliation(s)
- Oscar Alonso‐Luna
- Programa de Maestria y Doctorado en Ciencias Medicas, Odontologicas y de la SaludCiudad Universitaria, Universidad Nacional Autonoma de MexicoMexico CityMexico
| | | | - Jorge Melendez‐Zajgla
- Laboratorio de Genomica Funcional del CancerInstituto Nacional de Medicina GenomicaMexico CityMexico
| | - Rodrigo Barquera
- Department of ArchaeogeneticsMax Plank Institute for Evolutionary Anthropology (MPI‐EVA)LeipzigGermany
| | | | | | | | | | | |
Collapse
|
2
|
Rogawski DS, Tong E, Campen C. Spinal Neurofibromatosis (SNF): A Variant Phenotype of Neurofibromatosis Type 1 (NF1). J Pediatr 2023; 261:113571. [PMID: 37339702 DOI: 10.1016/j.jpeds.2023.113571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Revised: 06/13/2023] [Accepted: 06/14/2023] [Indexed: 06/22/2023]
Affiliation(s)
- David S Rogawski
- Department of Neurology and Neurological Sciences, Stanford Medicine, Palo Alto, California
| | - Elizabeth Tong
- Department of Radiology, Stanford Medicine, Palo Alto, California
| | - Cynthia Campen
- Department of Neurology and Neurological Sciences, Stanford Medicine, Palo Alto, California
| |
Collapse
|
3
|
Baradaran Bagheri A, Aghajanian S, Taghi Doulabi A, Chavoshi-Nejad M, Sorouredin Abadi S. Case report: Bilateral spinal neurofibromatosis. Front Neurol 2022; 13:976929. [PMID: 36034297 PMCID: PMC9412232 DOI: 10.3389/fneur.2022.976929] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Accepted: 07/27/2022] [Indexed: 11/22/2022] Open
Abstract
Spinal neurofibromatosis (SNF) is a rare form of Neurofibromatosis in which neurofibromas exist bilaterally throughout all spinal roots. Despite previous attempts made to characterize and classify the disease as a separate clinical form of the disease, the low incidence rate of the disease and scarcity of previous reports calls for further studies and reports to elaborate this clinical entity. The patient in this report was a 36-year-old man presenting with lower limb weakness, unsteady gait, and paresthesia. The patient also presented with multiple cutaneous café-au-lait spots, cutaneous neurofibromas, and a large neurocutaneous neurofibroma of right facial nerve. Magnetic resonance imaging (MRI) of spine revealed bilateral spinal neurofibromas across all spinal cord roots. MRI study of head revealed no abnormalities in the brain and optic tract. The patient fulfilled both NIH criteria as well as revised criteria for NF1. Despite total spinal cord involvement, surgical intervention was withheld from the patient due to high propensity of recurrence as seen with previous attempts in removing peripheral neurofibromas, slow progression of symptoms, and lack of significant pain and impairment. SNF is often described as a form of disease with infrequent presentation of classical NF1 symptoms other than spinal tumors. The case presented here however, presented with several cutaneous neurofibromas and café-au-lait spots. Considering the positive outcome of surgical intervention in a few other reports, the decision to surgically intervene should be left to the clinical judgement of the participating surgeon, patient preference and socioeconomic background in a case-by-case manner.
Collapse
Affiliation(s)
- Ali Baradaran Bagheri
- Department of Neurosurgery, Shahid Madani Hospital, Alborz University of Medical Sciences, Karaj, Iran
| | - Sepehr Aghajanian
- Department of Neurosurgery, Shahid Madani Hospital, Alborz University of Medical Sciences, Karaj, Iran
- Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
- *Correspondence: Sepehr Aghajanian
| | - Aliasghar Taghi Doulabi
- Department of Neurosurgery, Shahid Madani Hospital, Alborz University of Medical Sciences, Karaj, Iran
- Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
| | - Mehdi Chavoshi-Nejad
- Department of Neurosurgery, Shahid Madani Hospital, Alborz University of Medical Sciences, Karaj, Iran
| | - Somayeh Sorouredin Abadi
- Department of Internal Medicine, Shahid Madani Hospital, Alborz University of Medical Sciences, Karaj, Iran
| |
Collapse
|
4
|
He Q, Jiang J, Yang J, Zeng J, Zhang H, Zhang Z. A novel mutation of the NF1 gene in a Chinese family with neurofibromatosis type 1. Am J Transl Res 2022; 14:5139-5145. [PMID: 35958499 PMCID: PMC9360891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2022] [Accepted: 06/22/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND Mutations in the neurofibromin 1 (NF1) gene are associated with clinical manifestations of neurofibromatosis type 1 (NF1). OBJECTIVE To clarify the relationship between NF1 variants and disease phenotype. METHODS Peripheral blood samples were collected from a patient and her relatives and genomic DNA was extracted for next-generation sequencing (NGS) to detect potential variants; the results were validated by Sanger sequencing. RESULTS A novel frameshift variant c.4508_c.4509delAT (p.Asn1503fsTer26) was detected in exon 34 of the NF1 gene in the patient and her daughter, but not in any other (healthy) family member. This c.4508_c.4509delAT (p.Asn1503fsTer26) frameshift variant of NF1 may underlie NF1 in this family. CONCLUSIONS This finding expands the spectrum of pathogenic mutations of the NF1 gene, which could aid genetic counseling and prenatal diagnosis.
Collapse
Affiliation(s)
- Qi He
- Department of Dermatology, Affiliated Hospital of North Sichuan Medical CollegeNanchong 637000, Sichuan, China
| | - Jingjing Jiang
- Department of Dermatology, Affiliated Hospital of North Sichuan Medical CollegeNanchong 637000, Sichuan, China
| | - Jiao Yang
- Department of Dermatology, Affiliated Hospital of North Sichuan Medical CollegeNanchong 637000, Sichuan, China
| | - Junjie Zeng
- Department of Dermatology, Taikang Sichuan Southwest Hospital Company LimitedChengdu 610000, Sichuan, China
| | - Huan Zhang
- Department of Dermatology, Affiliated Hospital of North Sichuan Medical CollegeNanchong 637000, Sichuan, China
| | - Zhengzhong Zhang
- Department of Dermatology, Affiliated Hospital of North Sichuan Medical CollegeNanchong 637000, Sichuan, China
| |
Collapse
|
5
|
Ning Z, Yang Z, Chen G, Wu W, He L, Sun Y, Cai D, Zhang W. Spinal neurofibromatosis with NF1 mutation in a classic neurofibromatosis type 1 family: A case report and literature review. Mol Genet Genomic Med 2019; 8:e1035. [PMID: 31713330 PMCID: PMC6978228 DOI: 10.1002/mgg3.1035] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2019] [Revised: 10/14/2019] [Accepted: 10/16/2019] [Indexed: 01/23/2023] Open
Abstract
Background Spinal neurofibromatosis (SNF) is a related form of Neurofibromatosis type 1 (NF1) with a low incidence. Here, we report a SNF patient with NF1 (OMIM *613113) mutation in a classic NF1 family to enrich the case data. Methods We presented the clinical data of a 27‐year‐old female suffered from SNF. Two NF1 individuals (the mother and the brother) in the patient's family were also described. In the SNF patient, tumors in cervical were removed by surgical operation after the spinal MRI evaluation. Hematoxylin‐eosin staining and immunohistochemistry were performed to better characterize the excised tumors. NF1 exons of the patient and her NF1 families were further sequenced by the next‐generation sequencing technology. Results The patient developed irregular café‐au‐lait macules, multi‐subcutaneous nodules, recurrent numbness, and weakness of both lower extremities. Multiple neurofibromas were found in the whole spine by spinal MRI. Tumor‐like cells and hyperplasia of ganglion cells were found in the excised tissue by H&E staining and immunohistochemistry, respectively. One‐year follow‐up on the SNF patient showed that after the surgery lower limb pain, numbness and convulsion were completely relieved. A common germ‐line pathogenic mutation (NM_000267.3:c.1721 + 3A>G) was found in both the SNF patient and her classic NF1 families. Conclusion A case of SNF with classic NF1 mutation in a classic NF1 family was identified for the first time, indicating that SNF may share the same gene mutation with NF1, while the different manifestation of NF1 and SNF may be related to gene modification.
Collapse
Affiliation(s)
- Zeqian Ning
- The Neurosurgical Research Institute, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China.,Department of Neurosurgery, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China.,Guangdong Provincial Engineering and Technology Research Center of Stem Cell Therapy for Pituitary Disease, Guangzhou, China
| | - Zhiqian Yang
- Guangdong Provincial Engineering and Technology Research Center of Stem Cell Therapy for Pituitary Disease, Guangzhou, China.,Critical disease stem cell therapy innovation team, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China
| | - Gaofei Chen
- Guangdong Provincial Engineering and Technology Research Center of Stem Cell Therapy for Pituitary Disease, Guangzhou, China.,Critical disease stem cell therapy innovation team, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China
| | - Wenjiao Wu
- The Neurosurgical Research Institute, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China.,Department of Neurosurgery, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China
| | - Longshuang He
- The Neurosurgical Research Institute, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China.,Department of Neurosurgery, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China.,Guangdong Provincial Engineering and Technology Research Center of Stem Cell Therapy for Pituitary Disease, Guangzhou, China
| | - Yesheng Sun
- The Neurosurgical Research Institute, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China.,Department of Neurosurgery, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China
| | - Dongpeng Cai
- The Neurosurgical Research Institute, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China.,Department of Neurosurgery, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China
| | - Wei Zhang
- The Neurosurgical Research Institute, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China.,Department of Neurosurgery, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China.,Guangdong Provincial Engineering and Technology Research Center of Stem Cell Therapy for Pituitary Disease, Guangzhou, China.,Critical disease stem cell therapy innovation team, First Affiliated Hospital of Guangdong Pharmaceutics University, Guangzhou, China
| |
Collapse
|